---
figid: PMC10239578__12905_2023_2420_Fig5_HTML
figtitle: Differential molecular pathway expression according to chemotherapeutic
  response in ovarian clear cell carcinoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10239578
filename: 12905_2023_2420_Fig5_HTML.jpg
figlink: /pmc/articles/PMC10239578/figure/Fig4/
number: F4
caption: 'Postulated mechanisms involved in platinum-resistant OCCC. Red box/circle:
  significantly upregulated gene; blue box, significantly downregulated gene; gray
  box/circle: not significantly expressed gene or not included in this panel. GF,
  growth factor; FGF, fibroblast growth factor; NGF, nerve growth factor; EFNA5, ephrin-A5;
  ECM, extracellular matrix; RELN, reelin; RTK, receptor tyrosine kinase; PDGFRA,
  platelet-derived growth factor receptor, alpha polypeptide; ITGB8, integrin, beta
  8; ITGA8, integrin, alpha 8; GRB2, growth factor receptor-bound protein-2; GSK3,
  glycogen synthase kinase-3; CCND1, cyclin D1; CCDN3, cyclin D3'
papertitle: Differential molecular pathway expression according to chemotherapeutic
  response in ovarian clear cell carcinoma.
reftext: Min Yin, et al. BMC Womens Health. 2023;23:298.
year: '2023'
doi: 10.1186/s12905-023-02420-1
journal_title: BMC Women's Health
journal_nlm_ta: BMC Womens Health
publisher_name: BioMed Central
keywords: Ovarian clear cell carcinoma | Gene expression profiling | Drug resistance
  | Platinum
automl_pathway: 0.8158427
figid_alias: PMC10239578__F4
figtype: Figure
redirect_from: /figures/PMC10239578__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10239578__12905_2023_2420_Fig5_HTML.html
  '@type': Dataset
  description: 'Postulated mechanisms involved in platinum-resistant OCCC. Red box/circle:
    significantly upregulated gene; blue box, significantly downregulated gene; gray
    box/circle: not significantly expressed gene or not included in this panel. GF,
    growth factor; FGF, fibroblast growth factor; NGF, nerve growth factor; EFNA5,
    ephrin-A5; ECM, extracellular matrix; RELN, reelin; RTK, receptor tyrosine kinase;
    PDGFRA, platelet-derived growth factor receptor, alpha polypeptide; ITGB8, integrin,
    beta 8; ITGA8, integrin, alpha 8; GRB2, growth factor receptor-bound protein-2;
    GSK3, glycogen synthase kinase-3; CCND1, cyclin D1; CCDN3, cyclin D3'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF9
  - FGF11
  - RELN
  - COL2A1
  - NGF
  - PDGFRA
  - ITGB8
  - ITGA8
  - GRB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - GSK3A
  - GSK3B
  - BAD
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - MDM2
  - BCL2
  - TP53
  - TP63
  - TP73
---
